These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 22845187)

  • 21. Androgen deficiency in long-term intrathecal opioid administration.
    Kim CH; Garcia R; Stover J; Ritchie K; Whealton T; Ata MA
    Pain Physician; 2014; 17(4):E543-8. PubMed ID: 25054405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain.
    Anderson VC; Burchiel KJ
    Neurosurgery; 1999 Feb; 44(2):289-300; discussion 300-1. PubMed ID: 9932882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
    Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cost utilization analysis of intrathecal therapy for refractory cancer pain: identifying factors associated with cost benefit.
    Brogan SE; Winter NB; Abiodun A; Safarpour R
    Pain Med; 2013 Apr; 14(4):478-86. PubMed ID: 23461787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Priapism--a rare complication following continuous epidural morphine and bupivacaine infusion.
    Ruan X; Couch JP; Shah RV; Liu H; Wang F; Chiravuri S
    Pain Physician; 2007 Sep; 10(5):707-11. PubMed ID: 17876369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Audit of intrathecal drug delivery for patients with difficult-to-control cancer pain shows a sustained reduction in pain severity scores over a 6-month period.
    Mitchell A; McGhie J; Owen M; McGinn G
    Palliat Med; 2015 Jun; 29(6):554-63. PubMed ID: 25690600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between spousal or significant other solicitous responses and opioid dose in patients with chronic pain.
    Cunningham JL; Hayes SE; Townsend CO; Laures HJ; Hooten WM
    Pain Med; 2012 Aug; 13(8):1034-9. PubMed ID: 22776030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of dosing frequency of sustained-release opioid preparations in patients with chronic nonmalignant pain.
    Gallagher RM; Welz-Bosna M; Gammaitoni A
    Pain Med; 2007; 8(1):71-4. PubMed ID: 17244106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
    Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
    Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
    Nicholson B; Ross E; Sasaki J; Weil A
    Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain.
    Naliboff BD; Wu SM; Schieffer B; Bolus R; Pham Q; Baria A; Aragaki D; Van Vort W; Davis F; Shekelle P
    J Pain; 2011 Feb; 12(2):288-96. PubMed ID: 21111684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
    Enting RH; Oldenmenger WH; van der Rijt CC; Wilms EB; Elfrink EJ; Elswijk I; Sillevis Smitt PA
    Cancer; 2002 Jun; 94(11):3049-56. PubMed ID: 12115396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R; Kayser H; Sittl R
    Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions--the ACCPT Study.
    Adams EH; Chwiecko P; Ace-Wagoner Y; Mangefrida B; Duerden ME; Perdikis GC; Kunkel FA; Ghalie R
    Pain Pract; 2006 Dec; 6(4):254-64. PubMed ID: 17129306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful Discontinuation of Systemic Opioids After Implantation of an Intrathecal Drug Delivery System.
    Caraway D; Walker V; Becker L; Hinnenthal J
    Neuromodulation; 2015 Aug; 18(6):508-15; discussion 515-6. PubMed ID: 26053626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trialing and Maintenance Dosing Using a Low-Dose Intrathecal Opioid Method for Chronic Nonmalignant Pain: A Prospective 36-Month Study.
    Grider JS; Etscheidt MA; Harned ME; Lee J; Smith B; Lamar C; Bux A
    Neuromodulation; 2016 Feb; 19(2):206-19. PubMed ID: 26477685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy.
    Kumar K; Kelly M; Pirlot T
    Surg Neurol; 2001 Feb; 55(2):79-86; discussion 86-8. PubMed ID: 11301086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids.
    Rubinstein AL; Carpenter DM; Minkoff JR
    Clin J Pain; 2013 Oct; 29(10):840-5. PubMed ID: 24384986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.